Adam S. Grossman
2017
In 2017, Adam S. Grossman earned a total compensation of $2.7M as Director, President and Chief Executive Officer at ADMA Biologics, a 248% increase compared to previous year.
Compensation breakdown
| Bonus | $222,210 |
|---|---|
| Option Awards | $1,435,450 |
| Salary | $494,400 |
| Other | $508,088 |
| Total | $2,660,148 |
Grossman received $1.4M in option awards, accounting for 54% of the total pay in 2017.
Grossman also received $222.2K in bonus, $494.4K in salary and $508.1K in other compensation.
Rankings
In 2017, Adam S. Grossman's compensation ranked 4,174th out of 14,666 executives tracked by ExecPay. In other words, Grossman earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,174 out of 14,666 | 72nd |
Division Manufacturing | 1,460 out of 5,770 | 75th |
Major group Chemicals And Allied Products | 418 out of 2,074 | 80th |
Industry group Drugs | 320 out of 1,730 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 60 out of 316 | 81st |
Source: SEC filing on April 27, 2018.
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2017.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019